ADMA Biologics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade ADMA Biologics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ADMA

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. 

CEO
Adam S. Grossman
CEOAdam S. Grossman
Employees
647
Employees647
Headquarters
Ramsey, New Jersey
HeadquartersRamsey, New Jersey
Founded
2004
Founded2004
Employees
647
Employees647

ADMA Key Statistics

Market cap
2.18B
Market cap2.18B
Price-Earnings ratio
14.10
Price-Earnings ratio14.10
Dividend yield
—
Dividend yield—
Average volume
3.94M
Average volume3.94M
High today
$10.29
High today$10.29
Low today
$9.68
Low today$9.68
Open price
$10.02
Open price$10.02
Volume
2.79M
Volume2.79M
52 Week high
$20.46
52 Week high$20.46
52 Week low
$7.21
52 Week low$7.21

Stock Snapshot

As of today, ADMA Biologics(ADMA) shares are valued at $9.72. The company's market cap stands at 2.18B, with a P/E ratio of 14.10.

During the trading session on 2026-10-02, ADMA Biologics(ADMA) shares reached a daily high of $10.29 and a low of $9.68. At a current price of $9.72, the stock is +0.5% higher than the low and still -5.5% under the high.

Trading volume for ADMA Biologics(ADMA) stock has reached 2.79M, versus its average volume of 3.94M.

The stock's 52-week range extends from a low of $7.21 to a high of $20.46.

The stock's 52-week range extends from a low of $7.21 to a high of $20.46.

ADMA News

Simply Wall St 12h
Discovering US Market's Undiscovered Gems October 2026

Over the last seven days, the United States market has experienced a slight decline of 1.0%, yet it remains up by 11% over the past year with earnings projected...

Discovering US Market's Undiscovered Gems October 2026
Simply Wall St 3d
Yield Process Rollout Could Be A Big Deal For ADMA Biologics Stock

ADMA Biologics has become a focus for investors after swings in recent performance, as attention turns to its plasma-derived therapies business, its FDA-approve...

Yield Process Rollout Could Be A Big Deal For ADMA Biologics Stock

People also own

Based on the portfolios of people who own ADMA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.